Modulation of adenovirus-mediated gene transfer by nitric oxide

被引:19
作者
Haddad, IY
Sorscher, EJ
Garver, RI
Hong, J
Tzeng, E
Matalon, S
机构
[1] UNIV ALABAMA,DEPT ANESTHESIOL,BIRMINGHAM,AL 35233
[2] UNIV ALABAMA,DEPT PEDIAT,BIRMINGHAM,AL 35233
[3] UNIV ALABAMA,DEPT PHYSIOL & BIOPHYS,BIRMINGHAM,AL 35233
[4] UNIV ALABAMA,DEPT MED,BIRMINGHAM,AL 35233
[5] UNIV PITTSBURGH,DEPT SURG,PITTSBURGH,PA
关键词
D O I
10.1165/ajrcmb.16.5.9160832
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We assessed the role of . NO in recombinant adenovirus-mediated gene transfer both in vitro and in vivo. NIH3T3 fibroblasts, stably transfected with the human inducible nitric oxide synthase, but lacking tetrahydrobiopterin (NIH3T3/iNOS [inducibile nitric oxide synthase]), were infected with replication-deficient adenovirus (E1-deleted), containing either the luciferase or the Lac Z reporter genes (AdCMV-Luc and AdCMV-Lac Z; 1-10 plaque forming units [pfu]/cell). Incubation of infected cells with sepiapterin (50 mu M), a precursor of tetrahydrobiopterin, progressively increased nitrate/nitrite levels in the medium and decreased both luciferase and beta-galactosidase protein expression to approximately 60% of their corresponding control values, 24 h later. NIH3T3/iNOS cells had normal ATP (adenosine 5'-triphosphate) levels and did not release LDH(lactic dehydrogenase) into the medium. Pretreatment of these cells with N-G-monomethyl-L-arginine (L-NMMA; 1 mM), an inhibitor of iNOS, prevented the sepiapterin mediated induction of . NO and restored gene transfer to baseline values. Incubation bf NIH3T3/iNOS with 8-bromo-cGMP (400 mu M) in the absence of sepiapterin, or exposure of AdCMV-Luc to large concentrations of . NO, did not alter the efficacy of gene transfer. . NO produced by NIH3T3/iNOS cells also suppressed beta-galactosidase expression in NIH3T3 cocultured cells stably transfected with beta-galactosidase gene, suggesting . NO inhibited gene expression at either the transcriptional or posttranscriptional levels. To investigate the effects of inhaled . NO on gene transfer in vivo, CD1 mice received an intratracheal instillation of AdCMV-Luc (4 x 10(9) pfu in 80 mu l of saline) and exposed to . NO (25 ppm in room air) for 72 h. At that time, no significant degree of lung inflammation was detected by histological examination. However, lung luciferase activity decreased by 53% as compared with air breathing controls (P < 0.05; n greater than or equal to 8). We concluded that overproduction of . NO decreases the efficiency of adenovirus-mediated gene transfer in lung cells in the absence of cytotoxicity or inflammation.
引用
收藏
页码:501 / 509
页数:9
相关论文
共 54 条
[1]   HYPERSECRETION OF MUCIN IN RESPONSE TO INFLAMMATORY MEDIATORS BY GUINEA-PIG TRACHEAL EPITHELIAL-CELLS IN-VITRO IS BLOCKED BY INHIBITION OF NITRIC-OXIDE SYNTHASE [J].
ADLER, KB ;
FISCHER, BM ;
LI, HF ;
CHOE, NH ;
WRIGHT, DT .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1995, 13 (05) :526-530
[2]  
ALVING K, 1993, EUR RESPIR J, V6, P1368
[3]   CONSTITUTIVE AND INDUCIBLE NITRIC-OXIDE SYNTHASE GENE-EXPRESSION, REGULATION, AND ACTIVITY IN HUMAN LUNG EPITHELIAL-CELLS [J].
ASANO, K ;
CHEE, CBE ;
GASTON, B ;
LILLY, CM ;
GERARD, C ;
DRAZEN, JM ;
STAMLER, JS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (21) :10089-10093
[4]   NITRIC-OXIDE SYNTHASE ACTIVITY IS ELEVATED IN INFLAMMATORY LUNG-DISEASE IN HUMANS [J].
BELVISI, M ;
BARNES, PJ ;
LARKIN, S ;
YACOUB, M ;
TADJKARIMI, S ;
WILLIAMS, TJ ;
MITCHELL, JA .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 283 (1-3) :255-258
[5]   NITRIC-OXIDE AS A MEDIATOR OF OXIDANT LUNG INJURY DUE TO PARAQUAT [J].
BERISHA, HI ;
PAKBAZ, H ;
ABSOOD, A ;
SAID, SI .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (16) :7445-7449
[6]  
Brigham K L, 1994, Prog Clin Biol Res, V388, P361
[7]   EVIDENCE FOR AN ANTIVIRAL EFFECT OF NITRIC-OXIDE - INHIBITION OF HERPES-SIMPLEX VIRUS TYPE-1 REPLICATION [J].
CROEN, KD .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (06) :2446-2452
[8]   A PHASE-1 STUDY, IN CYSTIC-FIBROSIS PATIENTS, OF THE SAFETY, TOXICITY, AND BIOLOGICAL EFFICACY OF A SINGLE ADMINISTRATION OF A REPLICATION DEFICIENT, RECOMBINANT ADENOVIRUS CARRYING THE CDNA OF THE NORMAL CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR GENE IN THE LUNG [J].
CRYSTAL, RG ;
JAFFE, A ;
BRODY, S ;
MASTRANGELI, A ;
MCELVANEY, NG ;
ROSENFELD, M ;
CHU, CS ;
DANEL, C ;
HAY, J ;
EISSA, T .
HUMAN GENE THERAPY, 1995, 6 (05) :643-666
[9]  
EIGLER A, 1995, J IMMUNOL, V154, P4048
[10]  
ERICKSON JR, 1991, NEW ENGL J MED, V265, P478